Mayer Davidson to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Mayer Davidson has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.052
-
Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.
Score: 0.052
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.